In-Vitro Diagnostics Market Industry Outlook and Forecast 2020-2030 | COVID-19 Implications And Growth

The Business Research Company offers "In-Vitro Diagnostics Global Market Report 2020-30: Covid 19 Implications And Growth" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market's historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.

The global in-vitro diagnostics market is expected to grow from $57.9 billion in 2019 to $71.3 billion in 2020 at a compound annual growth rate (CAGR) of 23.2%. The growth of this market is mainly due to the increased diagnostic testing in laboratories, hospitals, and other testing sites across various country to detect the pandemic COVID-19 virus. The need for rapid diagnostic testing such as molecular and RT PCR based testing to identify people infected by coronavirus is driving the in-vitro diagnostics market. The market is then expected to stabilize and grow at a CAGR of 6% from 2021 and reach $81.3 billion in 2023.

Place a DIRECT PURCHASE ORDER of The Entire 140+ Pages Report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=1968

The in-vitro diagnostics devices (or) equipment manufacturing market consists of sales of in-vitro diagnostic equipment and related services by entities (organizations, sole traders and partnerships) that produce in-vitro diagnostics. This industry includes establishments that produce diagnostic devices used in microbiological diagnosis, hematological diagnosis, molecular diagnosis, point of care diagnosis and others.

Companies in this market are very active with multiple strategic collaborations and agreements. Top companies in the in-vitro diagnostic market are strategically partnering and collaborating with other companies to broaden their products, technologies and services. For instance, In February 2015, Roche acquired Signature Diagnostics to strengthen its cancer diagnostics effort with Signature's expertise in both next-generation sequencing (NGS) assays and biobanks . In February 2014, Thermo Fisher Scientific acquired the Life Technologies Corporation to transform into a major player in the segment of next-generation sequencing space.

In-Vitro Diagnostics Market Segmentation: -
By Type
Point-of-Care Diagnostics Devices And Equipment
Immunochemistry Diagnostic Devices And Equipment
Clinical Chemistry Diagnostics Devices And Equipment
Molecular Diagnostics Devices And Equipment
Microbiology Diagnostic Devices And Equipment
Hemostasis Diagnostic Devices And Equipment
Hematology Diagnostic Devices And Equipment
Immunohematology Diagnostic Devices And Equipment

By End User
Hospitals And Clinics
Diagnostic Laboratories
Others

By Type of Expenditure
Public
Private

By Product
Instruments/Equipment
Disposables

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report-2020-30-covid-19-implications-and-growth

Few Points From Table Of Content
1. Executive Summary
2. Report Structure
3. In-Vitro Diagnostics Market Characteristics
4. In-Vitro Diagnostics Market Product Analysis
5. In-Vitro Diagnostics Market Supply Chain
......
20. Key Mergers And Acquisitions In The In-Vitro Diagnostics Market
21. Market Background: Medical Equipment Market
22. Recommendations
23. Appendix
24. Copyright And Disclaimer

The report covers the trends and market dynamics of the In-Vitro Diagnostics Market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Request for a Sample Copy of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=1968&type=smp

Some of the key players involved in the In-Vitro Diagnostics Market are Siemens Healthineers; F. Hoffmann-La Roche Ltd; Danaher (Beckman Coulter Inc); Abbott Laboratories Inc; Thermo Fisher Scientific Inc

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/

About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.

This release was published on openPR.